GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allos Therapeutics, Inc. (ALTH) [hlAlert]

Rating:
Outperform
ALTH
down 69.07 %

Allos Therapeutics, Inc. (ALTH) upgraded to Outperform by Wachovia

Posted on: Thursday,  Dec 4, 2008  8:25 AM ET by Wachovia

Wachovia rated Outperform Allos Therapeutics, Inc. (NASDAQ: ALTH) on 12/04/2008, when the stock price was $5.95. Since
then, Allos Therapeutics, Inc. has lost 69.08% as of 09/05/2012's recent price of $1.84.
If you would have followed this Wachovia's recommendation on ALTH, you would have lost 69.07% of your investment in 1371 days.

Allos Therapeutics is a pharmaceutical company focused on developing andcommercializing innovative small molecule drugs, initially for improving cancer treatments. The company's lead product candidate is RSR13. RSR13 is a synthetic small molecule that increases the release of oxygen from hemoglobin, the oxygen-carrying protein contained within red blood cells.

Wachovia offers a full range of products and services to meet the needs of corporate and institutional clients nationwide. These include capital raising, market making, and financial advisory products and services, to name just a few. We have the experience and resources you need to help your business grow and succeed. With a unified culture and integrated platform, ours is an organization that executes without distraction. We are focused and proactive, working as a team to deliver the ideas and capital for your needs.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/4/2008 8:25 AM Buy
None
5.95
as of 12/24/2008
1 Week down  -1.37 %
1 Month down  -14.92 %
3 Months down  -22.70 %
1 YTD down  -6.04 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/4/2007 9:25 AM Hold
None
7.43

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy